Raymond Douglas, MD, PhD
Chief Scientific Officer
Dr. Raymond Douglas is an experienced board-certified aesthetic and reconstructive oculoplastic specialist. To date, he has held several prestigious positions at the UCLA School of Medicine, Harbor-UCLA Medical Center, Greater Los Angeles Veterans Hospital, Veterans Administration Ann Arbor Healthcare System and the University of Michigan Kellogg Eye Center. He is the current Director of the Orbital and Thyroid Eye Disease program at the prestigious Cedars-Sinai Medical Center in Los Angeles.
In addition to his private practices, Dr. Douglas is a clinical research author, advocate and educator internationally recognized for his groundbreaking research on treatments and restorative surgical techniques for Thyroid Eye Disease. He has published more than 100 peer-reviewed articles and textbook chapters and his special interest in Thyroid Eye Disease and lectures on the topic on a national and international basis. Dr. Douglas, with his team, pioneered breakthrough research understanding the pathways involved in TED, and leading to the identification of Tepezza. He was the principal investigator of the international clinical trials that led to FDA approval, and the first person in the world to treat patients with Tepezza following its approval by the FDA.
Dr. Douglas graduated from the University of Pennsylvania, where he completed his medical training and his PhD in immunology and autoimmune inflammatory disorders. He then went on to complete a sub-specialized fellowship in Orbital Facial Plastic and Reconstructive Surgery at the UCLA Jules Stein Eye Institute.